Guanfacine
Product Images NDC 42291-324

Product Visual Gallery

This gallery contains 12 technical images submitted to the FDA as part of the official labeling for Guanfacine (NDC 42291-324). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Avkare, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Label 4229132401 Guanfacine 2018.08

Guanfacine Extended-Release Tablets 1 mg by AvKARE displayed on a white carton label. The label includes warnings such as tablets should not be crushed, chewed, or broken before swallowing. It contains 100 tablets, is marked Rx Only, and features the AvKARE logo and product NDC 42291-324-01. Additional pharmaceutical information and storage instructions are visible.*

FDA Label Image

Label 4229132501 Guanfacine Er 2018 2mg

Label for guanfacine extended-release tablets, 2 mg strength, by AvKARE. The label indicates the tablets should not be crushed, chewed, or broken before swallowing and that the package contains 100 tablets. It includes storage instructions, manufacturer details, and a barcode.*

FDA Label Image

Label 4229132601 Guanfacine Er 2019 3mg

Label for guanfacine Extended-Release Tablets 3 mg by AvKARE. The label includes the NDC 42291-326-01 and specifies a count of 100 tablets. It states that tablets should not be crushed, chewed, or broken before swallowing and carries the designation Rx Only. Additional storage and usage instructions are also visible.*

FDA Label Image

Label 4229132701 Guanfacine Er 2019 4mg

Label for AvKARE Guanfacine Extended-Release Tablets 4 mg. The label includes warnings against crushing, chewing, or breaking tablets before swallowing. It indicates the bottle contains 100 tablets and is for prescription use only. Additional details include storage instructions and manufacturer information for AvKARE, Inc.*

FDA Label Image

15a84d83-figure-01 (Guanfacine 1)

Chemical structure diagram of guanfacine hydrochloride showing its molecular framework with chlorine atoms indicated, consistent with the active ingredient guanfacine from the provided product data by AvKARE.*

FDA Label Image

15a84d83-figure-02 (Guanfacine 2)

A line graph comparing guanfacine plasma concentration (ng/mL) over 24 hours for two formulations: Guanfacine Extended-Release 1 mg QD and Immediate-Release Guanfacine 1 mg QD. The graph shows plasma concentration on the y-axis and time in hours on the x-axis.*

FDA Label Image

15a84d83-figure-03 (Guanfacine 3)

A pharmacokinetic interaction graph showing fold changes and 90% confidence intervals in Cmax and AUC for guanfacine when coadministered with various CYP3A4/5 inhibitors and inducers including Ketoconazole, Fluconazole, Rifampin, Efavirenz, Oral Methylphenidate, and Lisdexamfetamine Dimesylate, comparing changes relative to reference.*

FDA Label Image

15a84d83-figure-04 (Guanfacine 4)

A forest plot illustrating the pharmacokinetic interaction effects of oral methylphenidate and lisdexamfetamine dimesylate on guanfacine. It shows fold change and 90% confidence intervals for Cmax and AUC parameters, with a reference line at 1.0 indicating no change relative to reference values.*

FDA Label Image

15a84d83-figure-05 (Guanfacine 5)

Packaging label for guanfacine tablets from AvKARE. The label includes brand and generic names, packaging details, and dosage guidance, primarily in English and Spanish. The bottle container is amber with a white cap and a white label featuring various safety, storage, and regulatory information.*

FDA Label Image

15a84d83-figure-06 (Guanfacine 6)

Packaging label of guanfacine tablets by AvKARE. The white rectangular label includes the drug name guanfacine and contains printed information, barcodes, and a warning statement. The label is sterile and designed for prescription medication.*

FDA Label Image

15a84d83-figure-07 (Guanfacine 7)

The image shows a rectangular carton for guanfacine tablets. The label includes the proprietary name "guanfacine" prominently. The labeler, AvKARE, is also displayed. The packaging features a predominantly blue and yellow color scheme with text blocks, including dosing and regulatory information boxes, but specific strength or dosage form details are not visible in the image.*

FDA Label Image

15a84d83-figure-08 (Guanfacine 8)

The image shows a prescription pill bottle label for guanfacine by AvKARE. The label includes standard drug information sections such as warnings, directions, storage information, and manufacturer details. It is a typical pharmacy bottle label with clear black text on a white background and a barcode at the bottom.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.